GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace

Mallinckrodt has agreed to buy Ocera Therapeutics in a deal that could hit $117M. Source: BioSpace

Physicians collaborating with Retrotope previously received approval from the FDA to test RT001 in Expanded Access trials of two patients having Infantile Neuroaxonal Dystrophy. Source: BioSpace

The Crestwood, KY-based company plans to raise $150M by offering 10.7 million shares at a price range of $13 to $15. Source: BioSpace

Investors and analysts are wondering if the company should buy a biotech to bolster its pipeline and bottom line. Source: BioSpace

Dupilumab added to standard therapies significantly reduced the use of maintenance oral corticosteroids (OCS) by 70% on average. Source: BioSpace

Shares of Voyager have fallen more than 12 percent in premarket trading after Sanofi Genzyme walked away from its $845M gene therapy treatment for Parkinson’s disease. Source: BioSpace

Based on feedback from the FDA, Stemline remains on track to begin submission of its BLA in the 4Q17-1Q18 timeframe. Source: BioSpace

Astra and Incyte are pushing forward on the development of immunotherapy combination treatments. Source: BioSpace

Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen. Source: BioSpace